companies making glp-1 drugs Check In 9 Companies Developing Next-Generation GLP-1

The Kraus 2014 Nature Paper: Why Adipose Research Specifically The 2014 Nature paper by Kraus and colleagues (titled "Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity") established the adipose-NNMT connection that anchors all subsequent NNMT-inhibition research in fat biology

In early August, Novo Nordisk announced that Wegovy reduces the risk of heart attack, stroke or heart-related death in people with cardiovascular disease and obesity by 20%, a result expected to boost use of the medicine even further

How Does Gut Bacteria Affect Weight

Three compounds, 2% NaHCO 3 , 2% Na 2 CO 3 , and 2% NaH 2 PO 4 , were incorporated as an intragranular excipient in AD formulations

Thus, even small variations in GLP-1 responses may influence metabolic outcomes

doi: 10.1586/14779072.2.2.203 11 LicataGArganoCDi ChiaraTParrinelloGScaglioneR